Kate Haviland - Insider Trading & Ownership

Location
Blueprint Medicines Corporation, 38 Sidney Street, Suite 200, Cambridge, MA
Summary
The estimated net worth of Kate Haviland is at least $2.64M dollars as of July 21, 2025. Kate Haviland is the Chief Executive Officer, Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $2.54M. Kate Haviland is the Director of Bicara Therapeutics Inc. and owns shares of Bicara Therapeutics Inc. (BCAX) stock worth about $98.5K.
Signature
/s/ Melissa Masse, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Kate Haviland

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BPMC Blueprint Medicines Corp Chief Executive Officer, Director $2.54M -$2.04M -44.5% Jul 17, 2025
BCAX Bicara Therapeutics Inc. Director $98.5K Jun 9, 2025
FULC Fulcrum Therapeutics, Inc. Director Jun 26, 2025

Insider Transactions Reported by Kate Haviland:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.